MedTech Daily: 14 New Press Releases for Friday, September 5, 2025


In This Issue:

Every morning we scan the headlines of the 250+ publicly traded medical technology companies so that you don't have to!

Here are the press categories for today:

Category:

  • Finance: 2
  • Clinical & Regulatory: 3
  • Products & Patents: 5
  • General Announcements: 3
  • Leadership Updates: 1

Finance

Pro-Dex, Inc. (PDEX | DoD: -1.57% | YTD: -1.34% | SmallCap: 128M)

  • Profile: A medical device company that designs and manufactures surgical drivers and shavers and motion control systems
  • Reporting: Pro-Dex, Inc. Announces Fiscal 2025 Fourth Quarter and Full-Year Results (Full Text)

STRATA Skin Sciences, Inc. (SSKN | DoD: -9.57% | YTD: -41.58% | SmallCap: 10M)

  • Profile: A medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions
  • Financing: STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering (Full Text)

Clinical & Regulatory

ClearPoint Neuro, Inc. (CLPT | DoD: +8.10% | YTD: -28.70% | SmallCap: 333M)

  • Profile: A global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine
  • FDA Clearance: ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners (Full Text)

Medtronic plc (MDT | DoD: +0.65% | YTD: +17.63% | LargeCap: 108.8B)

  • Profile: A global leader in healthcare technology
  • Clinical: Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints (Full Text)

Myriad Genetics, Inc. (MYGN | DoD: -0.15% | YTD: -49.70% | SmallCap: 423M)

  • Profile: A molecular diagnostic testing and precision medicine company, develops and provides molecular tests
  • Clinical: Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology (Full Text)

Products & Patents

Bio-Rad Laboratories, Inc. (BIO | DoD: +0.48% | YTD: -11.26% | MidCap: 5.9B)

  • Profile: Manufactures and distributes life science research and clinical diagnostic products in the United States
  • Product: Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc. (Full Text)

Koninklijke Philips N.V. (PHG | DoD: +2.14% | YTD: +15.07% | MidCap: 21.1B)

  • Profile: A leading health technology company focused on improving people‚Äôs health and well-being through meaningful innovation
  • Product: Far more than intelligent lighting: Philips Hue reimagines the smart home (Full Text)

OrthoPediatrics Corp. (KIDS | DoD: -0.91% | YTD: -9.44% | SmallCap: 494M)

  • Profile: A company focused exclusively on advancing the field of pediatric orthopedics
  • Partnership: OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc. (Full Text)

Owlet, Inc. (OWLT | DoD: -3.18% | YTD: +65.91% | SmallCap: 101M)

  • Profile: The pioneer of smart infant monitoring
  • Product: Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa (Full Text)

Zimmer Biomet Holdings, Inc. (ZBH | DoD: -0.27% | YTD: +0.76% | MidCap: 18.3B)

  • Profile: A global medical technology leader in the spinal and orthopedic therapy space
  • Event: Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference (Full Text)

General Announcements

AptarGroup, Inc. (ATR | DoD: +2.40% | YTD: -9.40% | MidCap: 10.3B)

  • Profile: Designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets
  • Event: Aptar Announces 2025 Investor Day (Full Text)

Biodesix, Inc. (BDSX | DoD: +5.05% | YTD: -70.05% | SmallCap: 45M)

  • Profile: A leading diagnostics solutions company
  • Event: Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference (Full Text)

iSpecimen Inc. (ISPC | DoD: -0.25% | YTD: -75.82% | SmallCap: 3M)

  • Profile: Provides biospecimens to life science researchers worldwide
  • Announcement: iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions (Full Text)

Leadership Updates

electroCore, Inc. (ECOR | DoD: -3.71% | YTD: -70.63% | SmallCap: 37M)

  • Profile: A commercial-stage bioelectronic medicine and wellness company
  • Leadership Update: electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board (Full Text)

The MedTech Daily Newsletter

We track the 250+ publicly traded MedTech companies so you don't have to!

Read more from The MedTech Daily Newsletter

In This Issue: Every morning we scan the headlines of the 250+ publicly traded medical technology companies so that you don't have to! Here are the press categories for today: Category: Finance: 4 Clinical & Regulatory: 1 Products & Patents: 1 General Announcements: 4 Finance FONAR Corporation (FONR | DoD: -0.51% | YTD: +3.97% | SmallCap: 90M) Profile: Engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human...

In This Issue: Every morning we scan the headlines of the 250+ publicly traded medical technology companies so that you don't have to! Here are the press categories for today: Category: Finance: 10 Clinical & Regulatory: 11 Products & Patents: 28 General Announcements: 16 Leadership Updates: 6 Mergers & Acquisitions: 4 Finance AptarGroup, Inc. (ATR | DoD: -0.58% | YTD: -10.85% | MidCap: 10.3B) Profile: Designs and manufactures a range of drug delivery, consumer product dispensing, and active...

In This Issue: Every morning we scan the headlines of the 250+ publicly traded medical technology companies so that you don't have to! Here are the press categories for today: Category: Finance: 3 Clinical & Regulatory: 8 Products & Patents: 7 General Announcements: 6 Leadership Updates: 1 Mergers & Acquisitions: 1 Finance Burning Rock Biotech Limited (BNR | DoD: -1.78% | YTD: +12.31% | SmallCap: 3M) Profile: Develops and sells cancer therapy selection tests Reporting: Burning Rock Reports...